|
Volumn 102, Issue 11, 2009, Pages 1170-1172
|
Electroconvulsive therapy for malignant catatonia in adolescence
|
Author keywords
Adolescents; Benzodiazepines; Electroconvulsive therapy (ECT); Malignant catatonia; Sickle cell anemia
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTICONVULSIVE AGENT;
ANTIVIRUS AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZODIAZEPINE;
CHLORPROMAZINE;
HALOPERIDOL;
LORAZEPAM;
OLANZAPINE;
PSYCHOTROPIC AGENT;
STEROID;
ADOLESCENT;
AFRICAN AMERICAN;
AGITATION;
ANTIBIOTIC THERAPY;
ARTICLE;
CASE REPORT;
CATATONIA;
DISEASE COURSE;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG WITHDRAWAL;
ELECTROCONVULSIVE THERAPY;
ENCEPHALITIS;
HUMAN;
MALE;
MALIGNANT CATATONIA;
PSYCHOSIS;
SEIZURE;
SICKLE CELL ANEMIA;
TREATMENT INDICATION;
TREATMENT RESPONSE;
ADOLESCENT;
ANTI-ANXIETY AGENTS;
CATATONIA;
DIAGNOSIS, DIFFERENTIAL;
ELECTROCONVULSIVE THERAPY;
HUMANS;
LORAZEPAM;
MALE;
NEUROLEPTIC MALIGNANT SYNDROME;
|
EID: 73849134710
PISSN: 00384348
EISSN: None
Source Type: Journal
DOI: 10.1097/SMJ.0b013e3181b9e39c Document Type: Article |
Times cited : (17)
|
References (15)
|